Safety, pharmacokinetics and pharmacodynamics of bi 705564, a covalent inhibitor of brutons tyrosine kinase in phase 1 clinical trials in healthy volunteers

Authors
Category Primary study
JournalLupus Science and Medicine
Year 2019
This article has no abstract
Epistemonikos ID: 89ef39d945ac6a850135fab5634dd04c67636ce0
First added on: Feb 10, 2025